000 01124 a2200337 4500
005 20250513225352.0
264 0 _c20010215
008 200102s 0 0 eng d
022 _a0001-6314
024 7 _a10.1034/j.1600-0404.2000.102006354.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aErdemoglu, A K
245 0 0 _aValproic acid in prophylaxis of refractory migraine.
_h[electronic resource]
260 _bActa neurologica Scandinavica
_cDec 2000
300 _a354-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aFemale
650 0 4 _aGABA Agents
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMigraine without Aura
_xdrug therapy
650 0 4 _aRecurrence
650 0 4 _aSeverity of Illness Index
650 0 4 _aTreatment Outcome
650 0 4 _aValproic Acid
_xpharmacology
700 1 _aOzbakir, S
773 0 _tActa neurologica Scandinavica
_gvol. 102
_gno. 6
_gp. 354-8
856 4 0 _uhttps://doi.org/10.1034/j.1600-0404.2000.102006354.x
_zAvailable from publisher's website
999 _c11066139
_d11066139